Virax Biolabs in September of 2022 started distributing monkeypox virus antigen test kits in markets accepting the CE mark, such as the European Union. Shares of Virax are up 10% to $1.41 in afternoon trading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.